The Latest
-
Novavax begins phase one of coronavirus vaccine trial after $388M Gates-backed group funding
-
Merck to buy Austrian vaccine maker as it jumps into COVID-19 race
-
Merck Joins Race For Covid-19 Vaccine; Shares Rise 4.4% In Pre-Market Trading
-
Markets surge on vaccine hopes, lockdowns easing